KR20030057545A - 잠복형 안티트롬빈 ｉｉｉ의 제조방법 - Google Patents

잠복형 안티트롬빈 ｉｉｉ의 제조방법 Download PDF

Info

Publication number
KR20030057545A
KR20030057545A KR10-2003-7005757A KR20037005757A KR20030057545A KR 20030057545 A KR20030057545 A KR 20030057545A KR 20037005757 A KR20037005757 A KR 20037005757A KR 20030057545 A KR20030057545 A KR 20030057545A
Authority
KR
South Korea
Prior art keywords
buffer
ammonium sulfate
sample
sulfate
hepes
Prior art date
Application number
KR10-2003-7005757A
Other languages
English (en)
Korean (ko)
Inventor
칼손궤란
Original Assignee
옥타파르마 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by 옥타파르마 아게 filed Critical 옥타파르마 아게
Publication of KR20030057545A publication Critical patent/KR20030057545A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR10-2003-7005757A 2000-11-08 2001-11-08 잠복형 안티트롬빈 ｉｉｉ의 제조방법 KR20030057545A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
SE0004086-5 2000-11-08
US25214800P 2000-11-20 2000-11-20
US60/252,148 2000-11-20
PCT/SE2001/002473 WO2002038610A1 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Publications (1)

Publication Number Publication Date
KR20030057545A true KR20030057545A (ko) 2003-07-04

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7005757A KR20030057545A (ko) 2000-11-08 2001-11-08 잠복형 안티트롬빈 ｉｉｉ의 제조방법

Country Status (15)

Country Link
EP (1) EP1332159A1 (no)
JP (1) JP2004522707A (no)
KR (1) KR20030057545A (no)
AU (1) AU2002214468A1 (no)
BR (1) BR0115188A (no)
CA (1) CA2428055A1 (no)
CZ (1) CZ20031277A3 (no)
EE (1) EE200300218A (no)
HU (1) HUP0301766A3 (no)
IL (1) IL155539A0 (no)
MX (1) MXPA03004030A (no)
NO (1) NO20032048D0 (no)
PL (1) PL360410A1 (no)
RU (1) RU2003117016A (no)
WO (1) WO2002038610A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
EP1848473B1 (en) 2005-02-07 2013-05-22 Hanuman LLC Plasma concentrator device
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
IL155539A0 (en) 2003-11-23
NO20032048L (no) 2003-05-07
RU2003117016A (ru) 2004-12-10
HUP0301766A2 (hu) 2003-08-28
AU2002214468A1 (en) 2002-05-21
HUP0301766A3 (en) 2005-12-28
WO2002038610A1 (en) 2002-05-16
CZ20031277A3 (cs) 2003-08-13
CA2428055A1 (en) 2002-05-16
NO20032048D0 (no) 2003-05-07
BR0115188A (pt) 2004-02-03
EE200300218A (et) 2003-08-15
EP1332159A1 (en) 2003-08-06
MXPA03004030A (es) 2004-02-12
JP2004522707A (ja) 2004-07-29
PL360410A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
KR20030057545A (ko) 잠복형 안티트롬빈 ｉｉｉ의 제조방법
US20020090711A1 (en) Process for preparing latent antithrombin III
EP0317376B2 (fr) Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
US5367064A (en) α-1-antichymotrypsin, analogues and methods of production
CN113846079A (zh) 新型胰蛋白酶同功异型物和其用途
CA2145517A1 (en) Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia - tissue factor complex
US8076462B2 (en) Method for producing antithrombin composition
US5777081A (en) Process for producing an inter-alpha-trypsin inhibitor concentrate for therapeutic use and concentrate thus obtained
US5079336A (en) α-1-antichymotrypsin, analogues and methods of production
WO2014089956A1 (zh) 一种制备α1-抗胰蛋白酶的方法
US5319072A (en) Human antithrombin-III preparation
US5583111A (en) Thrombin inhibitors
EP0282363B1 (fr) Procédé d'obtention d'un concentré d'alpha 1-antitrypsine à partir d'une fraction de plasma humain et son utilisation à titre de médicament
US5266465A (en) α-1-antichymotrypsin, analogues and methods of production
JPH09512422A (ja) カイメース阻害活性を有するα−１−抗キモトリプシン類似体
Karlsson et al. Separation of latent, prelatent, and native forms of human antithrombin by heparin affinity high-performance liquid chromatography
ZA200303492B (en) Process for the preparation of latent antithrombin III.
EP2511288B1 (en) Method of obtaining inhibitors of cysteine peptidases with an electrophoretic purity from biological materials
JP2915032B2 (ja) 新規なセリンプロテアーゼインヒビター蛋白質、これを含む医薬、この蛋白質のためにコードするｄｎａ配列及びこれら蛋白質、医薬及びｄｎａ配列を作り出す方法
Karlsson et al. Preparative conversion of native human antithrombin to the latent form
JPH0413698A (ja) 生理活性ペプチド
Karlsson Pasteurization of antithrombin without generation of the prelatent form of antithrombin
AU777294B2 (en) Process for the purification of antithrombin-III
CA2395489A1 (en) Process for the purification of antothrombin-iii
WO1990008158A1 (en) Method of recovering purified epi protein from a solution especially a fermentation solution

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application